Haemophilia bypassing agents (rFVIIa aPCC)

• ATC Code
• Indication
• NEMLC Recommendation
• Date Ratified

ATC CODE

• B02BD03

INDICATION

• Haemophilia with inhibitors (on demand, when presenting with a significant bleed).

NEMLC RECOMMENDATION

• Approved
  • Special Access
    • One bypassing agent to be available on the EML (most affordable). An alternative bypassing agent can be made available as emergency stock on a special access basis as approved by the PTC for patients not responding to EML item.

DATE RATIFIED

• 14 December 2017